The FDA made a major move this week regarding hormone replacement therapy (HRT) for menopausal women. Here I share my thoughts on this long awaited decision, and its unconventional style consistent with that of the new administration under HHS Secretary, Robert F. Kennedy Jr.
Research from my lab at UCLA has revealed why women are twice as likely as men to develop Alzheimer’s disease and multiple sclerosis (MS), and many experience “brain fog” during menopause. Maria Shriver asked for me to give more detail on the study in her Sunday Paper, which I happily obliged.